Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/25/2003US20030180316 Mixture of pertussis, tetanyus, diphtheria toxins
09/25/2003US20030180313 Genetic engineering; detection of humans immunodeficiency virus infections
09/25/2003US20030180307 Polypeptides; detecting infections using antibodies
09/25/2003US20030180304 Enzyme inhibitor; tuberculosis therapy
09/25/2003US20030180288 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
09/25/2003US20030180285 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti hsp90 antibodies
09/25/2003US20030180260 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
09/25/2003US20030180257 Alphavirus vectors for paramyxovirus vaccines
09/25/2003US20030180253 Stabilized liquid polypeptide-containing pharmaceutical compositions
09/25/2003US20030180246 Free-flowing anionic surfactant, alkanolamide and electrolytemixture
09/25/2003US20030180231 Cosmetics, skin disorders; sunscreen agents; aging resistance
09/25/2003US20030180179 Adsorber containing silver particles; chemical and biological warfare
09/25/2003DE19942230C2 Verwendung natriuretischer Peptide als antibiotisch wirksame Subsanzen zur Behandlung von bakteriellen Infektionen Use of natriuretic peptides as effective antibiotic used to treat bacterial infections Subsanzen
09/25/2003CA2488928A1 Method of modulating inflammatory response
09/25/2003CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003CA2479354A1 Broad-spectrum cephem compounds
09/25/2003CA2479315A1 Improvements in vaccination
09/25/2003CA2479307A1 Virus like particle from papillomavirus and their use in vaccine
09/25/2003CA2479304A1 Virus-like particles of human papillomavirus
09/25/2003CA2479212A1 Central airway administration for systemic delivery of therapeutics
09/25/2003CA2479211A1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
09/25/2003CA2479152A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003CA2478805A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
09/25/2003CA2478803A1 Methods of modulating cd200 receptors
09/25/2003CA2478795A1 Use of rapamycin for inhibiting cell death
09/25/2003CA2478763A1 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazine carboxylic acid derivatives effective against drug-resistant bacteria
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/25/2003CA2478651A1 Method of inducing an enhanced immune response against hiv
09/25/2003CA2478331A1 Peptide deformylase inhibitors
09/25/2003CA2478310A1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors
09/25/2003CA2478074A1 Percutaneous absorption promoters and compositions for treating athlete's foot
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/24/2003EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis
09/24/2003EP1346994A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds
09/24/2003EP1346745A1 Apparatus for treatment of tumor in the central nervous system (CNS)
09/24/2003EP1346727A2 Method for obtaining antigenic aggregates and the use thereof in formulations
09/24/2003EP1346725A1 Pharmaceutical composition comprising PIM-activated NKT cells, and therapeutic use thereof
09/24/2003EP1346724A1 Remedies for hepatitis c
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
09/24/2003EP1345960A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau-r4
09/24/2003EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences
09/24/2003EP1345954A2 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
09/24/2003EP1345953A2 Ketolide antibacterials
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345945A1 Streptogramin derivatives, preparation thereof and compositions containing same
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345913A2 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1345909A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
09/24/2003EP1345884A1 Anti-viral compounds
09/24/2003EP1345658A2 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
09/24/2003EP1345627A1 Targeted modification of intracellular compounds
09/24/2003EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
09/24/2003EP1345622A2 Eiav chimeric vaccine and diagnostic
09/24/2003EP1345621A1 i SALMONELLA /i VACCINE
09/24/2003EP1345617A2 Methods of modulating toll-related receptor (trr) signaling
09/24/2003EP1345616A2 Reducing cellular damage in the human body
09/24/2003EP1345614A1 IMPROVED AND STABLE EXTRACT FROM i HYPERICUM PERFORATUM L. /i , METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A TOPICAL MEDICAMENT
09/24/2003EP1345613A2 Probiotic compounds derived from lactobacillus casei strain ke01
09/24/2003EP1345606A2 Texaphyrin coordination compounds and uses thereof
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
09/24/2003EP1200065B1 Intravaginal clindamycin ovule composition
09/24/2003EP1177202B1 4'-c-ethynyl purine nucleosides
09/24/2003EP1177201B1 4'-c-ethynyl pyrimidine nucleosides
09/24/2003EP1124554B1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds
09/24/2003EP1100802B1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF
09/24/2003EP0975359B1 Use of compounds binding a cytoplasmic dipeptidase for the potentiation of the immune response
09/24/2003CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses
09/24/2003CN1444647A Novel probiotics for pet. food applications
09/24/2003CN1444600A Use of ADNF polypeptides for enhancing learning and memory
09/24/2003CN1444583A Method for preparing arylacetyl aminothiazole
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444564A Biphenyl carboxamides
09/24/2003CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor
09/24/2003CN1444483A Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides
09/24/2003CN1444482A Pharmaceutical compositions containing tobramycin and xanthan gum
09/24/2003CN1444480A Highly absorbable solid preparation
09/24/2003CN1444473A Composition and drug form for curing oral nosomycosis
09/24/2003CN1444469A Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases
09/24/2003CN1443770A Small RNA molecule for inhibiting SARS virus infection and its action target point
09/24/2003CN1443764A New condensed tricyclonucleoside compound containing acyclovir fragment and its preparation method
09/24/2003CN1443573A Recombinant human interferon alpha 2 b nose drops and its production method
09/24/2003CN1443572A Recombinant human interferon alpha 2 b lozenge and its production method
1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 1798